Landec Corporation Sets Second Quarter 2014 Conference Call For January 3, 2014 At 8 A.m. PT; Earnings Release Set For January 2, 2014 After Market

MENLO PARK, Calif., Dec. 12, 2013 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq:LNDC) will hold a conference call on Friday, January 3, 2014 at 8 a.m. Pacific time to discuss its results for the second quarter 2014. Financial results will be reported for the fiscal year 2014 second quarter ended November 24, 2013 after market close on January 2, 2014.

Landec's President and CEO, Gary T. Steele, will host the presentation with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.

Date: Friday, January 3, 2014 Time: 8 a.m. Pacific time (11 a.m. Eastern time) Toll Free Participant Dial-in Number: 866-793-1344 U.S. and International Toll Number: 703-639-1315  Conference ID: 1629361

Webcast: The webcast will be available for 30 days through February 2, 2014.

A replay of the teleconference will be available for one week until midnight Eastern Time, Friday, January 10, 2014.

Toll free replay dial in: 888-266-2081  International replay: 703-925-2533  Replay passcode: 1629361   

About Landec Corporation

Landec Corporation is a materials science company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets. Landec's subsidiary, Apio, has become the leader in US fresh-cut specialty packaged vegetables sold in North America based on combining Landec's proprietary food packaging technology and the strength of two major national brands, Eat Smart® and GreenLine®, with the capabilities of large scale processing and national distribution. Lifecore Biomedical, a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP validated manufacturing facility for supplying commercial, clinical and pre-clinical products. Landec will also periodically work with market-leading companies to develop and commercialize differentiated polymer-based products under R&D and royalty agreements. For more information about the company, visit Landec's website at .
CONTACT: Media and Industry Contact:                  At the Company:         Gregory S. Skinner         Vice President Finance and CFO         (650) 261-3677                  Investor Relations:         Matt Glover or Michael Koehler         949-574-3860

company logo

If you liked this article you might like

As Economic Danger Looms, Will Entrepreneurs Come to the Rescue?

AAR, Sensient Poised to Continue Stock Runs in 2017

4 Small Caps Looking Good in 2017: AAR, Sensient, Landec, LTC Properties

Four Small-Cap Value Stocks Rallying Into 2017

5 Hated Stocks You Should Love Instead